Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Message Exposure (Sequence: Flavor Then Regular) clinical trials
1 of 1 indexed Message Exposure (Sequence: Flavor Then Regular) trials are currently recruiting.
Corpus placement: #11,370 of 28,707 conditions by registered trial count.
1 US clinical trials · 1 currently recruiting · #11,370 of 28,707 conditions by registered trial count
Message Exposure (Sequence: Flavor Then Regular): 1 US clinical trial tracked, 1 recruiting.
Message Exposure (Sequence: Flavor Then Regular) is the subject of 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. The most active sponsor is University of Georgia, running 1 of these trials.
Enrollment posture brief
Registry condition message-exposure-sequence-flavor-then-regular
OPEN 1 | RECR 100% | LATE 0 | EARLY 0 | RANK #11370 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)
Message Exposure (Sequence: Flavor Then Regular) lists 1 open slots (100% of 1 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Message Exposure (Sequence: Flavor Then Regular) on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Message Exposure (Sequence: Flavor Then Regular) is recruiting above its size-band peers.
1 of 1 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
1 total, page 1 of 1
Phase Distribution
Phase data not available
Top Sponsors
Named interventions
Most-linked intervention names on Message Exposure (Sequence: Flavor Then Regular) records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Message Exposure (Sequence: Flavor Then Regular) trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Message Exposure (Sequence: Flavor Then Regular) page
1 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Message Exposure (Sequence: Flavor Then Regular) trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- University of Georgia sponsors the most Message Exposure (Sequence: Flavor Then Regular) trials on record, review their full trial history before evaluating a specific study. See University of Georgia's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Message Exposure (Sequence: Flavor Then Regular) condition card totals 1 registered trials; most-linked intervention Exposure to Anti-Vaping Messages (no message exposure); top US site state Georgia. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.